Prognostic value of the C-reactive protein to albumin ratio in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
- PMID: 33453709
- PMCID: PMC8283510
- DOI: 10.3906/sag-2003-188
Prognostic value of the C-reactive protein to albumin ratio in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Abstract
Background/aim: This study investigated whether baseline serum level of C-reactive protein (CRP)/albumin ratio is associated with infarct localization, number of vascular lesions, and in-hospital mortality in patients undergoing primary percutaneous coronary intervention (PCI) for acute ST elevation myocardial infarction (STEMI).
Methods: The study population consisted of 116 patients diagnosed with STEMI. The CRP/albumin ratio at first admission, cardiac troponin-I (cTnI), PCI results, and clinical outcomes were recorded.
Results: The mean CRP/albumin ratio, cTnI level, and mean number of vascular lesions were significantly higher in non-survivors than in survivors (p = 0.006, p = 0.004, and p = 0.007, respectively). Multivariate logistic regression analysis demonstrated that the CRP/ albumin ratio and number of coronary artery lesions were independent predictors of mortality in STEMI patients. According to these analyses, the presence of ≥ 2 vessel lesions was the most important predictor of mortality, with an odds ratio of 2.009 (95% confidence interval: 1.191–3.387, p = 0.009).
Conclusion: This study demonstrates the potential utility of the CRP/albumin ratio for predicting the clinical outcome of patients with STEMI. In addition, the presence of ≥ 2 vascular lesions contributed to a 2-fold increase in mortality rate in STEMI patients.
Keywords: CRP/albumin ratio; ST-elevation myocardial infarction; infarction localization; prognosis; vascular lesion number.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Conflict of interest statement
The authors have no conflicts of interest to declare. No funding support was used to carry out the research.
Figures
Similar articles
-
The C-Reactive Protein to Albumin Ratio Predicts Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.Heart Lung Circ. 2019 Nov;28(11):1638-1645. doi: 10.1016/j.hlc.2018.08.009. Epub 2018 Sep 9. Heart Lung Circ. 2019. PMID: 30293924
-
Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Heart Vessels. 2019 Oct;34(10):1600-1607. doi: 10.1007/s00380-019-01399-w. Epub 2019 Apr 16. Heart Vessels. 2019. PMID: 30993442
-
Usefulness of The C-Reactive Protein/Albumin Ratio for Predicting No-Reflow in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.Eur J Clin Invest. 2018 Jun;48(6):e12928. doi: 10.1111/eci.12928. Epub 2018 Apr 17. Eur J Clin Invest. 2018. PMID: 29577260
-
The prognostic value of admission mean platelet volume to platelet count ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Kardiol Pol. 2016;74(4):346-55. doi: 10.5603/KP.a2015.0179. Epub 2015 Sep 14. Kardiol Pol. 2016. PMID: 26365942
-
Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.BMC Cardiovasc Disord. 2018 May 2;18(1):75. doi: 10.1186/s12872-018-0812-6. BMC Cardiovasc Disord. 2018. PMID: 29716535 Free PMC article. Review.
Cited by
-
From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction.Int J Mol Sci. 2022 Aug 15;23(16):9168. doi: 10.3390/ijms23169168. Int J Mol Sci. 2022. PMID: 36012430 Free PMC article. Review.
-
A novel inflammatory biomarker, high-sensitivity C-reactive protein-to-albumin ratio, is associated with 5-year outcomes in patients with type 2 diabetes who undergo percutaneous coronary intervention.Diabetol Metab Syndr. 2023 Feb 6;15(1):14. doi: 10.1186/s13098-022-00977-9. Diabetol Metab Syndr. 2023. PMID: 36747210 Free PMC article.
-
Association of high-sensitivity C-reactive protein to albumin ratio with all-cause and cardiac death in coronary heart disease individuals: A retrospective NHANES study.PLoS One. 2025 May 28;20(5):e0322281. doi: 10.1371/journal.pone.0322281. eCollection 2025. PLoS One. 2025. PMID: 40435309 Free PMC article.
-
Non-linear Association of CAR with all-Cause and Cardiovascular Mortality in Coronary Heart Disease: A Retrospective Cohort Study from NHANES.Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241271382. doi: 10.1177/10760296241271382. Clin Appl Thromb Hemost. 2024. PMID: 39149979 Free PMC article.
-
Triglyceride-glucose index and hsCRP-to-albumin ratio as predictors of major adverse cardiovascular events in STEMI patients with hypertension.Sci Rep. 2024 Nov 15;14(1):28112. doi: 10.1038/s41598-024-79673-9. Sci Rep. 2024. PMID: 39548181 Free PMC article.
References
-
- Shrivastava AK Singh HV Raizada A Singh SK C-reactive protein, inflammation and coronary heart disease. The Egyptian Heart Journal . 2015;67:89–97.
-
- Madjid M Willerson JT Inflammatory markers in coronary heart disease. British Medical Bulletin . 2011;100:23–38. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous